Cardiac β-adrenoceptor activation and ventricular fibrillation under normal and ischaemic conditions

Cardiovascular Research

Volumn 32, Issue 6, 1996, Pages 1056-1063

  Bui Xuan, Bernard ^a   Aupetit, Jean F ^a   Freysz, Marc ^a   Loufoua, Joseph ^a   Faucon, Georges ^a   Timour, Quadiri ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

adrenoceptors; catecholamines; isoprenaline; myocardial ischemia; pig, anesthetized; ventricular fibrillation

Indexed keywords

BETA ADRENERGIC RECEPTOR; ISOPRENALINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ELECTROPHYSIOLOGY; FEMALE; HEART MUSCLE ISCHEMIA; HEART RATE; HEART VENTRICLE FIBRILLATION; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE; TACHYCARDIA; ACTION POTENTIAL; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTROSTIMULATION; HEART MUSCLE; HEART PACING; METABOLISM;

ACTION POTENTIALS; ADRENERGIC BETA-AGONISTS; ANIMALS; CARDIAC PACING, ARTIFICIAL; ELECTRIC STIMULATION; FEMALE; ISOPROTERENOL; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RECEPTORS, ADRENERGIC, BETA; SWINE; VENTRICULAR FIBRILLATION;

EID: 0030300052     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00156-3     Document Type: Article

References (38)

1. Schwartz PJ, Stone HL. The role of the autonomic nervous system in sudden coronary death. Ann NY Acad Sci. 382:1982;162-180.
2. Lombardi F, Verrier RL, Lown B. Relationship between sympathetic neural activity, coronary dynamics and vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion. Am Heart J. 105:1983;958-965.
3. Rehnqvist N. Prevention of sudden death by beta-blockade. Cardiovasc Drugs Ther. 4:1990;675-680.
4. A randomized trial of propranolol in patients with acute myocardial infarction I. Mortality results. J Am Med Assoc. 247:1982;1707-1714.
5. Randomized trial of intravenous atenolol among 16027 cases of suspected myocardial infarction. Lancet. 2:1986;57-65.
6. Puddu PE, Jouve R, Langlet F. Prevention of postischaemic ventricular fibrillation by long-term beta adrenoceptor blockade with acebutolol in the anaesthetised dog. Cardiovasc Res. 20:1986;721-726.
7. Hoffman BF, Siebens AA, Cranefield PF, Brooks CMcC. The effect of epinephrine and norepinephrine on ventricular vulnerability. Circ Res. 3:1955;140-147.
8. Han J, de Jalon PG, Moe GK. Adrenergic effects on ventricular vulnerability. Circ Res. 14:1964;516-524.
9. Vassalle M, Barnabei O. Norepinephrine and potassium fluxes in cardiac Purkinje fibers. Arch Ges Physiol. 322:1971;287-298.
10. Skinner JE, Lie JT, Entman HL. Modification of ventricular fibrillation latency following coronary artery occlusion in the conscious pig. The effect of psychological stress and beta-adrenergic blockade. Circulation. 51:1975;656-667.
11. + activity in swine. Circulation. 61:1980;768-778.
12. Verdouw PD, van Bremen RH, Verkeste CM, van der Giessen WJ. Antiarrhythmic action and protection of ischaemic myocardium after beta-blockade with bevantolol. Eur J Pharmacol. 111:1985;377-380.
13. Knopf H, McDonald FM, Bischoff A, Hirche HJ, Addicks K. Effect of propranolol on early postischemia arrhythmias and noradrenaline and potassium release of ischemic myocardium in anesthetized pigs. J Cardiovasc Pharmacol. 12:((suppl I)):1988;S41-S47.
14. James RGG, Arnold JMO, Allen JD, Pantridge JF, Shanks RG. The effects of heart rate, myocardial ischemia and vagal stimulation on the threshold for ventricular fibrillation. Circulation. 55:1977;311-317.
15. Boyett MR, Jewell BR. Analysis of the effects of changes in rate and rhythm upon electrical activity of the heart. Prog Biophys Mol Biol. 36:1980;1-52.
16. Aupetit JF, Timour Q, Loufoua-Moundanga J, Omar S, Chevrel G, Faucon G. Vulnerability to ventricular fibrillation related to ischaemia. Comparison of the acute effects of β-blockers and calcium antagonists. Arch Int Pharmacodyn. 327:1994;25-39.
17. Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term myocardial infarction intervention trials. Am J Cardiol. 57:1986;43F-49F.
18. Timour Q, Aupetit JF, Chevrel G, Loufoua-Moundanga J, Omar S, Faucon G. Time course of electrical fibrillation threshold during brief periods of myocardial ischemia and the genesis of fibrillation: role of calcium. Cardiovasc Drugs Ther. 8:1994;877-879.
19. Hagar JM, Hale SL, Kloner RA. Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in the rat. Circ Res. 68:1991;61-68.
20. Vegh A, Komori S, Szekeres L, Parratt JR. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res. 26:1992;487-495.
21. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
22. Aupetit JF, Timour Q, Chevrel G, Loufoua-Moundanga J, Omar S, Faucon G. Attenuation of the ischaemia-induced fall of electrical ventricular fibrillation threshold by a calcium antagonist, diltiazem. Naunyn-Schmiedeberg's Arch Pharmacol. 348:1993;509-514.
23. Aupetit JF, Timour Q, Loufoua-Moundanga J. Profibrillatory effects of lidocaine in the acutely ischemic porcine heart. J Cardiovasc Pharmacol. 25:1995;810-816.
24. Wit AL, Weiss MB, Berkowitz WD, Rosen KM, Steiner C, Damato AN. Pattern of atrioventricular conduction in the human heart. Circ Res. 27:1970;345-359.
25. Janse MJ, Wit AL. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev. 69:1989;1049-1169.
26. Gerstenblith G, Spear JF, Moore EN. Quantitative study of the effect of lidocaine on the threshold for ventricular fibrillation in the dog. Am J Cardiol. 30:1972;242-247.
27. Timour Chah Q, Bertrix L, Bouzouita K, Lang J, Faucon G. Study of the ventricular antifibrillatory effects of calcium channel blocking agents in comparison with lidocaine on canine normal heart in situ. Arch Int Pharmacodyn. 261:1983;238-248.
28. Mortality and morbidity in patients receiving encainide, flecainide or placebo. N Engl J Med. 324:1991;781-788.
29. Loufoua-Moundanga J, Omar S, Chevrel G, Aupetit JF, Timour Q, Faucon G. Aggravation by Ic antiarhythmic drugs of the gradual decrease of electrical threshold for fibrillation produced by ischaemia. Fundam Clin Pharmacol. 7:1993;188. (Abstract).
30. Lang J, Timour Chah Q, Charve P, Aupetit JF, El Chebly M, Faucon G. Role of calcium in the rate-dependent depression of atrioventricular nodal conduction in the dog heart under vagal influence. Int J Cardiol. 15:1987;65-76.
31. Franz MR, Schaefer J, Schöttler W, Seed WA, Noble MM. Electrical and mechanical restitution of the human heart at different rates of stimulation. Circ Res. 53:1983;815-822.
32. Boyett MR, Fedida D. A simple model of ion concentration changes in the heart during repetitive activity. J Physiol (Lond). 342:1983;52P-53P.
33. De Mello WC, Hoffman BF. Potassium ions and electrical activity of specialized cardiac fibers. Am J Physiol. 199:1960;1125-1130.
34. Lyons CJ, Burgess MJ, Abildskov JA. Effects of acute hyperkalemia on cardiac excitability. Am Heart J. 94:1997;755-763.
35. Coraboeuf E. Ionic basis of electrical activity in cardiac tissues. Am J Physiol. 234:1978;H101-H116.
36. Reuter H. Ion channels in cardiac cell membrane. Annu Rev Physiol. 46:1984;473-484.
37. Sutherland EW, Rall TW. The relation of adenosine-3′5′ phosphate and phosphorylase to the actions of catecholamines and other hormones. Pharmacol Rev. 12:1960;265-299.
38. Sutherland EW, Robison GA. The role of cyclic-3′5′ AMP in response to catecholamines and other hormones. Pharmacol Rev. 18:1966;145-161.